Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Shu-Wan Kau"'
Autor:
Lavinia P. Middleton, Gabriel N. Hortobagyi, Arif H. Kamal, Laura A. Granville, Aysegul A Sahin, Limin Hsu, Shu Wan Kau, Banu Arun, Guosheng Yin, Shaheenah Dawood
Publikováno v:
Cancer Investigation. 28:554-559
Glutathione-S-transferase-pi (GST-pi) is a detoxification enzyme expressed in breast cancer; however its involvement in chemotherapy sensitivity and prognosis is not well understood. We evaluated the expression of GSTpi and its predictive role of che
Autor:
Gabriel N. Hortobagyi, Francisco J. Esteva, Kristine Broglio, Melissa L. Bondy, V. Valero, Banu Arun, Cesar Santa-Maria, Abenaa M. Brewster, Shu Wan Kau, Daniel J. Booser, Aman U. Buzdar
Publikováno v:
JNCI: Journal of the National Cancer Institute. 100:1179-1183
There is limited prognostic information to identify breast cancer patients who are at risk for late recurrences after adjuvant or neoadjuvant systemic therapy (AST). We evaluated the residual risk of recurrence and prognostic factors of 2838 patients
Autor:
Shu Wan Kau, Sean E. McGuire, W. Fraser Symmans, Ana M. Gonzalez-Angulo, Gabriel N. Hortobagyi, Massimo Cristofanilli, Kristine Broglio, Shaheenah Dawood, Rabiul Islam, Thomas A. Buchholz, Funda Meric-Bernstam
Publikováno v:
The Oncologist. 13:6-15
Learning Objectives After completing this course, the reader will be able to: Define survival outcomes in women with early-stage breast cancer who achieve pathological complete response following primary systemic chemotherapy.Define the prognostic va
Autor:
Debby Frye, Shu Wan Kau, W. Fraser Symmans, Cornelia Liedtke, Chafika Mazouni, Marjorie C. Green, Fabrice Andre, Gabriel N. Hortobagyi, Lajos Pusztai, Ana M. Gonzalez-Angulo
Publikováno v:
Breast Cancer Research and Treatment. 108:183-190
We examined the correlation between HER2 expression and pathologic complete response (pCR) to paclitaxel/FAC (T/FAC) preoperative chemotherapy in breast cancer. Retrospective analysis of data including 534 patients treated with preoperative T/FAC was
Autor:
Rabiul Islam, S. Jackson, Gabriel N. Hortobagyi, Shaheenah Dawood, Valentina Guarneri, Herbert A. Fritsche, Vicente Valero, James M. Reuben, J. Lara, Massimo Cristofanilli, Kristine Broglio, Savitri Krishnamurthy, Naoto T. Ueno, Shu Wan Kau
Publikováno v:
Clinical Breast Cancer. 7:34-42
The detection of circulating tumor cells (CTCs) predicts overall survival in patients with metastatic breast cancer (MBC). However, it is unknown whether CTCs have superior value compared with other standard prognostic factors. We compared the progno
Autor:
Shu Wan Kau, Gabriel N. Hortobagyi, Ana M. Gonzalez-Angulo, Aman U. Buzdar, Kristine Broglio, Shaheenah Dawood, Florentia Peintinger, Rabiul Islam, William Fraser Symmans
Publikováno v:
Cancer. 110:1195-1200
BACKGROUND. A previously published prospective randomized phase 3 trial showed that administration of 24 weeks of primary systemic chemotherapy (PST) with paclitaxel and FEC75 (fluorouracil, epirubicin, cyclophosphamide) concurrently with trastuzumab
Autor:
Shu Wan Kau, Yu Shen, Francisco J. Esteva, Richard L. Theriault, Wenli Dong, Therese B. Bevers
Publikováno v:
Breast Cancer Research and Treatment. 102:347-356
To determine the influence of race on breast cancer treatment and on recurrence and breast cancer specific death.The study population consisted of 6,054 African-American or white women who were diagnosed with breast cancer and received at least one o
Autor:
Aman U. Buzdar, Sean E. McGuire, Thomas A. Buchholz, Massimo Cristofanilli, Roman Rouzier, Henry Mark Kuerer, Paolo Morandi, Ana M. Gonzalez-Angulo, Vicente Valero, Gabriel N. Hortobagyi, Susan L. Tucker, Alberto Ocaña, Shu Wan Kau, Eugene H. Huang
Publikováno v:
Journal of Clinical Oncology. 23:7098-7104
Purpose To identify clinicopathological factors predictive of distant metastasis in patients who had a pathologic complete response (pCR) after neoadjuvant chemotherapy (NC). Methods Retrospective review of 226 patients at our institution identified
Autor:
C R N Shu-Wan Kau, Kristine R. Broglio, Gabriel N. Hortobagyi, Vicente Valero, L D O Richard Theriault, Edgardo Rivera, Massimo Cristofanilli, Aman U. Buzdar, Emer O. Hanrahan, Guosheng Yin
Publikováno v:
Cancer. 104:1158-1171
BACKGROUND In three prospective, single-arm studies, the authors previously showed an improved outcome for anthracycline-naive patients with isolated sites of recurrent breast carcinoma (BC) who were treated with doxorubicin-based chemotherapy after
Autor:
Richard L. Theriault, Aman U. Buzdar, Banu Arun, Daniel J. Booser, Vicente Valero, Yesmin Eralp, Kristine Broglio, Shu-Wan Kau, Gabriel N. Hortobagyi, Julie Erlichman, Ana M. Gonzalez-Angulo
Publikováno v:
Cancer. 103:2466-2472
The purpose of the current study was to describe a population of young patients with breast carcinoma, their characteristics at the time of diagnosis, and the association of these characteristics with disease recurrence and survival.Four hundred fift